The Tumor Antigen Vaccine market is a subset of the larger Cancer Vaccine market. Tumor Antigen Vaccines are designed to stimulate the body's immune system to recognize and attack cancer cells. These vaccines are typically made from proteins or other molecules found on the surface of cancer cells. They are designed to trigger an immune response that will recognize and attack cancer cells.
Tumor Antigen Vaccines are being developed for a variety of cancers, including breast, lung, and prostate cancer. Clinical trials are underway to evaluate the safety and efficacy of these vaccines. The goal is to develop a vaccine that can be used to prevent or treat cancer.
The Tumor Antigen Vaccine market is a rapidly growing field, with many companies investing in research and development. Companies such as Merck, Pfizer, and GlaxoSmithKline are actively involved in the development of Tumor Antigen Vaccines. Other companies such as ImmunoCellular Therapeutics, ImmunoVaccine, and Oncolytics Biotech are also involved in the development of these vaccines. Show Less Read more
